Ci Investments Inc. Bristol Myers Squibb CO Transaction History

Ci Investments Inc.

$26.3 Billion
Q3 2024

A detailed history of Ci Investments Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ci Investments Inc. holds 123,738 shares of BMY stock, worth $7.18 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

123,738

Previous 142,376 13.09%

Holding current value

$7.18 Million

Previous $5.91 Million 8.27%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $739,183 - $964,516	-18,638 Reduced 13.09%	123,738 $6.4 Million
Q2 2024 Aug 12, 2024	BUY	$40.25 - $52.99 $270,721 - $356,410	6,726 Added 4.96%	142,376 $5.91 Million
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $1.32 Million - $1.49 Million	27,438 Added 25.36%	135,650 $7.36 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $2.2 Million - $2.63 Million	-45,454 Reduced 29.58%	108,212 $5.55 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $260,041 - $290,767	-4,492 Reduced 2.84%	153,666 $8.92 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $125,954 - $139,852	1,977 Added 1.27%	158,158 $10.1 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $318,167 - $360,874	-4,842 Reduced 3.01%	156,181 $10.8 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $728,353 - $862,473	10,636 Added 7.07%	161,023 $11.6 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $779 - $460,578	5,994 Added 4.15%	150,387 $10.7 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $4.28 Million - $4.72 Million	-58,964 Reduced 29.0%	144,393 $11.1 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $102,794 - $123,259	1,672 Added 0.83%	203,357 $14.9 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $6.67 Million - $7.77 Million	-124,309 Reduced 38.13%	201,685 $12.6 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $2.8 Million - $3.28 Million	-47,277 Reduced 12.67%	325,994 $19.3 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $389,228 - $423,869	-6,287 Reduced 1.66%	373,271 $24.9 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $2.55 Million - $2.86 Million	-42,925 Reduced 10.16%	379,558 $24 Million
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $5.21 Million - $5.91 Million	90,313 Added 27.19%	422,483 $26.2 Million
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $790,466 - $875,940	13,764 Added 4.32%	332,170 $20 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $10.5 Million - $12.3 Million	191,629 Added 151.15%	318,406 $18.7 Million
Q1 2020 Aug 07, 2020	SELL	$46.4 - $67.43 $236,176 - $343,218	-5,090 Reduced 3.86%	126,777 $7.07 Million
Q4 2019 Feb 11, 2020	SELL	$49.21 - $64.19 $1.02 Million - $1.33 Million	-20,749 Reduced 13.6%	131,867 $8.47 Million
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $6.53 Million - $7.74 Million	152,616 New	152,616 $7.74 Million
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $55.8 Million - $64.3 Million	-931,700 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$59.94 - $65.35 $8.63 Million - $9.41 Million	-143,980 Reduced 13.39%	931,700 $57.1 Million
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $59.4 Million - $68.6 Million	1,075,680	1,075,680 $68.6 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Bristol Myers Squibb CO Transaction History